Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells

Fig. 1

Box plot of serum sclerostin levels in controls (n = 121), T2D patients without CVD (n = 48), and T2D patients with CVD (n = 91). Box plot represents the minimum value, 25th percentile, median, 75th percentile, maximum value, and outliers for each group. The p-values between the different were performed by ANCOVA. * = p < 0.05 vs. Control; # = p < 0.05 vs. T2D without CVD. T2D, type 2 diabetes; CVD, cardiovascular disease.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840